Wells Fargo & Company Syneos Health, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$34.5 - $42.19 $3.35 Million - $4.1 Million	-97,146 Reduced 56.75%	74,040 $3.12 Million
Q1 2023 May 12, 2023	BUY	$33.32 - $40.98 $1.16 Million - $1.43 Million	34,882 Added 25.59%	171,186 $6.1 Million
Q4 2022 Feb 13, 2023	SELL	$25.32 - $51.45 $1.46 Million - $2.96 Million	-57,603 Reduced 29.71%	136,304 $5 Million
Q3 2022 Nov 14, 2022	SELL	$46.5 - $79.14 $3.18 Million - $5.41 Million	-68,363 Reduced 26.07%	193,907 $9.14 Million
Q2 2022 Aug 12, 2022	SELL	$63.06 - $84.75 $6.46 Million - $8.69 Million	-102,482 Reduced 28.1%	262,270 $18.8 Million
Q1 2022 May 16, 2022	SELL	$74.15 - $99.36 $2.42 Million - $3.24 Million	-32,593 Reduced 8.2%	364,752 $29.5 Million
Q4 2021 Feb 14, 2022	SELL	$86.01 - $102.89 $3.28 Million - $3.93 Million	-38,170 Reduced 8.76%	397,345 $40.8 Million
Q3 2021 Nov 15, 2021	BUY	$84.7 - $96.31 $455,770 - $518,244	5,381 Added 1.25%	435,515 $38.1 Million
Q2 2021 Aug 16, 2021	BUY	$76.44 - $89.57 $3.49 Million - $4.09 Million	45,714 Added 11.89%	430,134 $38.5 Million
Q1 2021 May 13, 2021	BUY	$67.36 - $80.76 $3.08 Million - $3.69 Million	45,671 Added 13.48%	384,420 $29.2 Million
Q4 2020 Feb 09, 2021	SELL	$53.08 - $69.86 $632,448 - $832,381	-11,915 Reduced 3.4%	338,749 $23.1 Million
Q3 2020 Nov 05, 2020	BUY	$51.29 - $65.09 $1.6 Million - $2.04 Million	31,282 Added 9.79%	350,664 $18.6 Million
Q2 2020 Aug 13, 2020	SELL	$34.32 - $62.43 $1.14 Million - $2.07 Million	-33,133 Reduced 9.4%	319,382 $18.6 Million
Q1 2020 May 14, 2020	BUY	$32.64 - $73.63 $11.5 Million - $26 Million	352,515 New	352,515 $13.9 Million

Others Institutions Holding SYNH

# of Institutions

Shares Held

731K

Call Options Held

Put Options Held

View Full List

About Syneos Health, Inc.

Ticker SYNH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,653,000
Description
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...

More about SYNH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account